Correlation Between Eliem Therapeutics and Hepion Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Eliem Therapeutics and Hepion Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Eliem Therapeutics and Hepion Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Eliem Therapeutics and Hepion Pharmaceuticals, you can compare the effects of market volatilities on Eliem Therapeutics and Hepion Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Eliem Therapeutics with a short position of Hepion Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Eliem Therapeutics and Hepion Pharmaceuticals.
Diversification Opportunities for Eliem Therapeutics and Hepion Pharmaceuticals
0.36 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Eliem and Hepion is 0.36. Overlapping area represents the amount of risk that can be diversified away by holding Eliem Therapeutics and Hepion Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Hepion Pharmaceuticals and Eliem Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Eliem Therapeutics are associated (or correlated) with Hepion Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Hepion Pharmaceuticals has no effect on the direction of Eliem Therapeutics i.e., Eliem Therapeutics and Hepion Pharmaceuticals go up and down completely randomly.
Pair Corralation between Eliem Therapeutics and Hepion Pharmaceuticals
Given the investment horizon of 90 days Eliem Therapeutics is expected to under-perform the Hepion Pharmaceuticals. But the stock apears to be less risky and, when comparing its historical volatility, Eliem Therapeutics is 1.09 times less risky than Hepion Pharmaceuticals. The stock trades about -0.24 of its potential returns per unit of risk. The Hepion Pharmaceuticals is currently generating about 0.0 of returns per unit of risk over similar time horizon. If you would invest 74.00 in Hepion Pharmaceuticals on September 2, 2024 and sell it today you would lose (7.00) from holding Hepion Pharmaceuticals or give up 9.46% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 96.88% |
| Values | Daily Returns |
Eliem Therapeutics vs. Hepion Pharmaceuticals
Performance |
| Timeline |
| Eliem Therapeutics |
| Hepion Pharmaceuticals |
Eliem Therapeutics and Hepion Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Eliem Therapeutics and Hepion Pharmaceuticals
The main advantage of trading using opposite Eliem Therapeutics and Hepion Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Eliem Therapeutics position performs unexpectedly, Hepion Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Hepion Pharmaceuticals will offset losses from the drop in Hepion Pharmaceuticals' long position.| Eliem Therapeutics vs. Pmv Pharmaceuticals | Eliem Therapeutics vs. MediciNova | Eliem Therapeutics vs. Pharvaris BV | Eliem Therapeutics vs. PepGen |
| Hepion Pharmaceuticals vs. Enveric Biosciences | Hepion Pharmaceuticals vs. Elevation Oncology | Hepion Pharmaceuticals vs. Ocean Biomedical | Hepion Pharmaceuticals vs. Zura Bio Limited |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
Other Complementary Tools
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk |